Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Patients With Advanced Solid Tumor × MEK inhibitor I × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Solid Tumor, Adult 1 Solid Tumor 1 Patients With Advanced Solid Tumor 1 Melanoma 1 Liver Neoplasms 1 Carcinoma, Hepatocellular 1

Interventions

MEK inhibitor I 1 1,1'-(4,4'-(((5-chloropyrimidine-2,4-diyl)bis(azanediyl))bis(3-methoxy-4,1-phenylene))bis(piperazine-4,1-diyl))diethanone 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06322095 2024-10-01

A Study of GH21 Combined With Previous Target Therapy or Immunotherapy in Patients With Advanced Solid Tumors

Suzhou Genhouse Bio Co., Ltd.

Phase 2 Recruiting

Other solid neoplasm

Patients With Advanced Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon ⚡